Association between disease-modifying antirheumatic drugs for rheumatoid arthritis and risk of incident dementia: a systematic review with meta-analysis
Background Dysregulation of several inflammatory cytokines including tumour necrosis factor (TNF) in dementia patients has also been identified as a key factor in the pathogenesis of rheumatoid arthritis (RA). We aimed to investigate the association of disease-modifying antirheumatic drugs (DMARDs)...
Main Authors: | Wenhui Xie, Shiyu Xiao, Zhuoli Zhang, Xiaolin Zhang, Yue Hou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-02-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/10/1/e004016.full |
Similar Items
-
Abstract 6 — Are Disease-Modifying Antirheumatic Drugs: for Rheumatoid Arthritis Associated with a Lower Risk of Dementia? A Systematic Review with Meta-Analysis
by: Wenhui Xie, et al.
Published: (2023-11-01) -
Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients
by: Judge, AD, et al.
Published: (2017) -
Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts.
by: Emery, P, et al.
Published: (1994) -
Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
by: Xia Y, et al.
Published: (2016-05-01) -
Lung lesion caused by the use of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
by: Yuriy Vladimirovich Murav'ev, et al.
Published: (2010-12-01)